Pages that link to "Q35608102"

The following pages link to The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia (Q35608102):

Displaying 25 items.

• The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors (Q24315774) (← links)
• The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers (Q24675681) (← links)
• Chronic eosinophilic leukemia with the FIP1L1-PDGFRalpha fusion gene in a patient with a history of combination chemotherapy (Q33370414) (← links)
• Response to imatinib mesylate in patients with hypereosinophilic syndrome. (Q33402403) (← links)
• FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia (Q33404894) (← links)
• Eosinophil survival and apoptosis in health and disease (Q33758139) (← links)
• The epigenetic signature of systemic insulin resistance in obese women (Q33895274) (← links)
• Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation (Q34321183) (← links)
• Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation (Q35072889) (← links)
• Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA (Q35114558) (← links)
• Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets (Q35629006) (← links)
• A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia (Q36892617) (← links)
• Biology of the eosinophil (Q37397520) (← links)
• Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5. (Q37755233) (← links)
• CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas (Q39016536) (← links)
• Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene (Q39685947) (← links)
• The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation (Q39818667) (← links)
• The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivo (Q40395721) (← links)
• Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib (Q41483025) (← links)
• A patient with shortness of breath and bilateral pulmonary infiltrates (Q41851997) (← links)
• Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction (Q46763652) (← links)
• Targeting cleavage and polyadenylation specific factor 1 via shRNA inhibits cell proliferation in human ovarian cancer (Q49866056) (← links)
• Cryptic chromosomal aberrations waiting to be discovered (Q81632616) (← links)
• Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement? (Q81791345) (← links)
• Systemic mastocytosis (Q83304407) (← links)